Menu
Back to Journals » Cancer Management and Research
Cancer Management and Research
ISSN: 1179-1322
Editor-in-Chief: Professor Yong Teng
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4943)
- Volume 17, 2025 (185)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Case Report: A Rare EGFR 20 Insertion Variant, P772_H773insGNP Mediates Resistance to Sunvozertinib but Is Sensitive to Furmonertinib
Wang Y, Zheng J, Wang J, Sheng L, Qu J, Zhou J
Cancer Management and Research 2025, 17:2277-2285
Published Date: 1 October 2025
Artificial Intelligence in Breast Cancer Diagnosis and Surgical Decision-Making: An Updated and Comprehensive Overview of Precision and Personalization in Current Evidence
Alenezi AM
Cancer Management and Research 2025, 17:2261-2275
Published Date: 30 September 2025
Angiogenesis and Immunosuppressive Niche in Hepatocellular Carcinoma: Reshaping Vascular - Immune Axis to Potentiate antiPD - 1/PD - L1 Therapy
Li W, Li GC, Luo CS, Yu QF, Cui M
Cancer Management and Research 2025, 17:2245-2259
Published Date: 29 September 2025
S100A6 Induces the Resistance to Gefitinib in Human Lung Adenocarcinoma PC9 Cell Lines with EGFR 19 Exon Mutations
Wang T, Shou X
Cancer Management and Research 2025, 17:2235-2244
Published Date: 29 September 2025
Preoperative Systemic Inflammation Response Index Predicts Survival Outcome for Previously Irradiated Metachronous Secondary Head and Neck Cancer Patients
Su YY, Chien CY, Tsai WL, Tsai MH, Fang FM
Cancer Management and Research 2025, 17:2221-2233
Published Date: 29 September 2025